Photobiomodulation (PBM) therapy involves using non-thermal light, specifically narrow-wavelength bands of red and near-infrared light from LED or laser sources, to affect cellular responses. This therapy primarily targets cytochrome-C-oxidase, which releases reactive oxygen species (ROS) and regulates cellular signaling pathways. PBM therapy has a strong safety record and is free of serious side-effects, making [...]
At the moment, there are no pharmacological treatments for Autism Spectrum Disorder (ASD) core features. There is a growing interest in non-pharmacological interventions for ASD, such as neuromodulation with brain photobiomodulation š§ DrĀ Pallanti Stefano, a Stanford University Professor and Director of Istituto di Neuroscienze, Florence, Italy, led an independent retrospective study with the Vielight [...]
In 2015, our dementia pilot trial made history by being the first to show efficacy of brain photobiomodulation (PBM) for dementia in humans with a home-use device.[1] In 2019, Dr. Linda Chao, a professor in the Departments of Radiology, Biomedical Imaging and Psychiatry at the University of California, verified our 2015 dementia pilot trial [...]
